From alleviating stress to promoting focus, creativity or a sense of calm, Lumina supports a holistic approach to mental and physical well-being, key considerations in the flourishing wellness sector.
“Lumina is the third entry in ABcann’s growing lineup of cannabis brands, joining Beacon Medical and FIRESIDE in our premium portfolio,” says Barry Fishman, CEO. “Our extensive experience growing premium cannabis, emphasis on quality, and dedication to an exceptional consumer experience can be seen in the superior products we deliver.”
Lumina was developed to be a health and wellness brand dedicated to non-combustible formats of cannabis and future innovations in the wellness space. Fostering a mind-body connection, Lumina products — expected to be available when the adult-use recreational cannabis market opens to Canadians on October 17, 2018 — will be produced in small batches at ABcann’s state-of-the-art, ISO 9001 certified facility. Lumina Oils, the first product group in the Lumina line, will come in three formulations to satisfy a variety of needs:
- CBD Oil: 0 mg/mL THC, 25 mg/mL CBD
- Balanced Oil: 12.5 mg/mL THC, 12.5 mg/mL CBD
- THC Oil: 25 mg/mL THC, 0 mg/mL CBD
The oils can be taken on their own, mixed with food or drink, or used in cooking or baking. Generally, while the effects of cannabis-infused oils take longer to surface, they last longer than combustible methods of delivery. In some personal wellness programs, they are used for a sense of serenity and relaxation, while others report increased mental clarity and focus.
“Lumina was created to address two powerful consumer trends: the belief that a healthy mind and a healthy body are connected, and the desire to be self-directed when it comes to taking care of one’s health,” says Sung Kang, Chief Marketing Officer. “Lumina Oils are just the first in a rich line of products we intend to develop as regulations evolve. Eventually, we see this brand carrying a wide array of lotions, creams, aromatherapy candles, bath bombs and other elevated products containing cannabis extracts that help people take care of their mind and body.”
ABcann Global is committed to providing quality cannabis products and services that improve lives. Every variable in ABcann’s growing, curing and harvesting process is precisely-controlled and monitored. ABcann’s indoor, high-tech craft growing environment translates into a superior product that is clean, consistent and repeatable, critical factors when delivering high quality.
With the emergence of the Canadian adult-use market, continued focus on the medical cannabis segment and a growing global opportunity — coupled with a healthy balance sheet — ABcann is well-positioned for success.
About ABcann
ABcann is recognized for high-quality, trusted products and services. It holds production and sales licenses from Health Canada, and its world-class indoor cultivation facility in Napanee, Ontario contains proprietary plant-growing technology, centred on its specially designed, environmentally controlled growing chambers. This approach results in the production of pharmaceutical-grade cannabis products. ABcann is expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, such as Germany, Australia, and Israel.
ABcann recently announced that it has entered into a definitive agreement to acquire 100% of the issued and outstanding share capital of Canna Farms Limited, a premium cannabis company in British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow.
SOURCE
Read More